Head-To-Head Survey: Cannabis Wheaton Income (OTCMKTS:CBWTF) versus Corpay (NYSE:CPAY)

Corpay (NYSE:CPAYGet Free Report) and Cannabis Wheaton Income (OTCMKTS:CBWTFGet Free Report) are both finance companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, profitability and analyst recommendations.

Risk and Volatility

Corpay has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500. Comparatively, Cannabis Wheaton Income has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Corpay and Cannabis Wheaton Income, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Corpay 0 3 12 0 2.80
Cannabis Wheaton Income 0 0 0 0 0.00

Corpay currently has a consensus price target of $426.08, suggesting a potential upside of 4.72%. Given Corpay’s stronger consensus rating and higher probable upside, analysts plainly believe Corpay is more favorable than Cannabis Wheaton Income.

Profitability

This table compares Corpay and Cannabis Wheaton Income’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Corpay 22.72% 42.18% 6.34%
Cannabis Wheaton Income 20.99% 19.84% 12.26%

Institutional & Insider Ownership

98.8% of Corpay shares are held by institutional investors. 5.2% of Corpay shares are held by company insiders. Comparatively, 4.6% of Cannabis Wheaton Income shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares Corpay and Cannabis Wheaton Income”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Corpay $4.53 billion 5.87 $1.07 billion $16.43 24.76
Cannabis Wheaton Income $108.41 million 1.67 $29.96 million $0.02 6.38

Corpay has higher revenue and earnings than Cannabis Wheaton Income. Cannabis Wheaton Income is trading at a lower price-to-earnings ratio than Corpay, indicating that it is currently the more affordable of the two stocks.

Summary

Corpay beats Cannabis Wheaton Income on 12 of the 14 factors compared between the two stocks.

About Corpay

(Get Free Report)

Volatus is a leader in innovative global aerial solutions for intelligence and cargo. With over 100 years of combined institutional knowledge in aviation, Volatus provides comprehensive solutions using both piloted and remotely piloted aircraft systems for a wide array of industries, including oil and gas, energy utilities, healthcare, public safety, and infrastructure. The Company is committed to enhancing operational efficiency, safety, and sustainability through cutting-edge aerial technologies.

About Cannabis Wheaton Income

(Get Free Report)

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. It focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. The company offers cannabis products under various forms, including vape catridges, infused pre-rolls, pre-rolled, vape pens, milled and dried flower, concentrates, chocolates, soft chews, oil drops, capsules, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. The company was incorporated in 1987 and is headquartered in Toronto, Canada.

Receive News & Ratings for Corpay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corpay and related companies with MarketBeat.com's FREE daily email newsletter.